PT Millennium Pharmacon International Tbk - Laporan Laba Rugi (TTM)

PT Millennium Pharmacon International Tbk
ID ˙ IDX
Laporan Laba Rugi (TTM)

Laporan Laba Rugi PT Millennium Pharmacon International Tbk menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 2,650,598 2,643,627 2,542,135 2,722,038 2,964,455 2,988,849 3,118,516 3,108,303 3,110,806 3,200,833 3,140,964 3,219,223 3,247,238 3,363,518 3,583,663 3,737,537 3,847,837 3,916,864 3,923,319 3,919,262
Change (%) -0.26 -3.84 7.08 8.91 0.82 4.34 -0.33 0.08 2.89 -1.87 2.49 0.87 3.58 6.55 4.29 2.95 1.79 0.16 -0.10
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 2,427,305 2,426,333 2,337,603 2,507,087 2,733,458 2,751,812 2,867,474 2,855,780 2,855,069 2,933,936 2,873,863 2,942,130 2,968,681 3,073,699 3,281,080 3,422,422 3,521,591 3,582,742 3,582,857 3,580,713
Change (%) -0.04 -3.66 7.25 9.03 0.67 4.20 -0.41 -0.02 2.76 -2.05 2.38 0.90 3.54 6.75 4.31 2.90 1.74 0.00 -0.06
% of Revenue 91.58 91.78 91.95 92.10 92.21 92.07 91.95 91.88 91.78 91.66 91.50 91.39 91.42 91.38 91.56 91.57 91.52 91.47 91.32 91.36
Gross Operating Profit 223,293 217,293 204,532 214,952 230,997 237,036 251,042 252,523 255,737 266,897 267,101 277,093 278,557 289,819 302,583 315,116 326,246 334,122 340,462 338,548
Change (%) -2.69 -5.87 5.09 7.46 2.61 5.91 0.59 1.27 4.36 0.08 3.74 0.53 4.04 4.40 4.14 3.53 2.41 1.90 -0.56
% of Revenue 8.42 8.22 8.05 7.90 7.79 7.93 8.05 8.12 8.22 8.34 8.50 8.61 8.58 8.62 8.44 8.43 8.48 8.53 8.68 8.64
SG&A 163,080 159,860 158,426 164,061 170,558 176,214 176,728 180,406 181,647 186,311 191,108 189,923 191,301 193,007 200,045 208,380 215,543 225,935 228,281 230,568
Change (%) -1.97 -0.90 3.56 3.96 3.32 0.29 2.08 0.69 2.57 2.57 -0.62 0.73 0.89 3.65 4.17 3.44 4.82 1.04 1.00
% of Revenue 6.15 6.05 6.23 6.03 5.75 5.90 5.67 5.80 5.84 5.82 6.08 5.90 5.89 5.74 5.58 5.58 5.60 5.77 5.82 5.88
R&D
Change (%)
% of Revenue
OpEx 2,592,430 2,590,855 2,500,837 2,678,996 2,914,382 2,931,374 3,048,266 3,037,943 3,034,958 3,126,933 3,069,621 3,123,619 3,155,644 3,270,801 3,485,859 3,650,053 3,755,500 3,820,430 3,822,559 3,821,848
Change (%) -0.06 -3.47 7.12 8.79 0.58 3.99 -0.34 -0.10 3.03 -1.83 1.76 1.03 3.65 6.58 4.71 2.89 1.73 0.06 -0.02
% of Revenue 97.81 98.00 98.38 98.42 98.31 98.08 97.75 97.74 97.56 97.69 97.73 97.03 97.18 97.24 97.27 97.66 97.60 97.54 97.43 97.51
Operating Income 58,168 52,771 41,297 43,043 50,074 57,475 70,250 70,361 75,848 73,900 71,343 95,603 91,594 92,717 97,805 87,484 92,337 96,434 100,760 97,414
Change (%) -9.28 -21.74 4.23 16.34 14.78 22.23 0.16 7.80 -2.57 -3.46 34.01 -4.19 1.23 5.49 -10.55 5.55 4.44 4.49 -3.32
% of Revenue 2.19 2.00 1.62 1.58 1.69 1.92 2.25 2.26 2.44 2.31 2.27 2.97 2.82 2.76 2.73 2.34 2.40 2.46 2.57 2.49
Interest Expense -53,985 -45,117 -40,930 -36,271 -35,306 -39,894 -40,226 -40,095 -37,269 -38,482 -42,097 -46,463 -51,843 -57,577 -59,190 -61,600 -65,238 -68,791 -70,658 -71,082
Change (%) -16.43 -9.28 -11.38 -2.66 13.00 0.83 -0.33 -7.05 3.26 9.39 10.37 11.58 11.06 2.80 4.07 5.91 5.45 2.71 0.60
% of Revenue -2.04 -1.71 -1.61 -1.33 -1.19 -1.33 -1.29 -1.29 -1.20 -1.20 -1.34 -1.44 -1.60 -1.71 -1.65 -1.65 -1.70 -1.76 -1.80 -1.81
Net Income 2,481 2,804 -3,080 2,264 9,106 9,571 19,784 20,180 23,400 24,464 19,205 33,687 27,353 33,088 34,343 25,293 26,873 16,929 20,163 18,326
Change (%) 13.02 -209.84 -173.51 302.15 5.11 106.70 2.00 15.96 4.55 -21.50 75.41 -18.80 20.97 3.79 -26.35 6.25 -37.00 19.10 -9.11
% of Revenue 0.09 0.11 -0.12 0.08 0.31 0.32 0.63 0.65 0.75 0.76 0.61 1.05 0.84 0.98 0.96 0.68 0.70 0.43 0.51 0.47

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista